Doctors of optometry have big role in catching giant cell arteritis before blindness

May 10, 2016
Study is the biggest to date on people suffering with giant cell arteritis.

A new study on giant cell arteritis (GCA) confirms the frontline role doctors of optometry can play in diagnosing the disease.

GCA occurs when the arteries in the head become inflamed. It typically happens to people over age 50 and more often in women. The international study, which involved 433 newly diagnosed patients in 23 countries, was the biggest to date on people suffering with GCA.

"The significance of this study on giant cell arteritis is that often the presenting symptom is anterior ischemic neuropathy, which can lead to blindness," says Dr. Saysha Blazier, O.D., who practices at Savoy Siegel + Desai in Jersey City, New Jersey, and is a member of AOA's Health Promotions Committee.

"As eye-care providers, we hold a key role in the immediate, proper treatment prior to clinical diagnosis so we can attempt to save vision in at least one eye as well as prevent other irreversible systemic sequelae," Dr. Blazier adds.

The study, conducted over a six-month period, was designed to:

  • Assess the frequency of GCA-associated blindness.
  • Evaluate the possible vascular risk factors.

Researchers say that previous studies had neither established GCA's frequency nor its risk factors, though cardiovascular disease had been previously linked as a risk factor.

"Six months after the diagnosis of GCA, the incidence of complete blindness in at least one eye was 7.9%," study co-author Max Yates, MBBS, of the University of East Anglia in England, told MedPage Today.

Further, the research linked GCA patients to strokes and peripheral vascular disease. Yates shared his results at the annual meeting of the British Society for Rheumatology in Glasgow, Scotland, in late April.

Symptoms include:

  • Double vision or vision loss
  • Persistent headaches
  • Fatigue
  • Dizziness

The study "suggests that blindness remains a major clinical problem and highlights the need for urgent referral and treatment," the authors wrote. "The association with prior vascular disease indicates a need for greater vigilance in this group."

Vigilance is where doctors of optometry come in.

"Key is the role of optometrists in the overall health care system, including communication with the rheumatologist, and then moving forward with social workers, occupational therapists and other providers to manage any vision loss, which would affect an individual's quality of life and their activities of daily living," Dr. Blazier adds.

The AOA follows all research closely, including potential treatments for GCA; however, more research is needed regarding influence on visual health.

Related News

AOA series addresses concerns about myopia management

With the prevalence of myopia on the rise worldwide, an AOA webinar attempts to erase concern over barriers to providing myopia management. The webinar kicked off a three-event series focused on raising awareness of myopia management as a standard of care especially for children. Next is “Meet the Myopia Experts” on Saturday, June 24, at Optometry’s Meeting® 2023 in Washington, D.C.

AOA serving patients through research in optometry

For the fifth consecutive year, the AOA is sponsoring the Investigator Initiated Research Award. Investigators are invited to electronically submit proposals by July 1 for projects designed to increase knowledge through basic clinical and/or translational science relative to the continuum of eye and vision care. The AOA provides a maximum of $50,000 in direct costs for research conduct. Eric Ritchey, O.D., Ph.D., talks about his current research on low-level light therapy for patients with meibomian gland dysfunction, which can lead to dry eye disease.

Marijuana sensibilities changing fast: Are you ready for patients’ questions?

Public support for marijuana legalization has never been higher in the U.S., but evidence of its clinical utility in glaucoma care remains clouded at best.